Buergers disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 23: Line 23:


==Overview==
==Overview==
'''Buerger's disease'''  is an acute [[inflammation]] and [[thrombosis]] (clotting) of [[artery|arteries]] and [[vein]]s of the hands and feet. It is strongly associated with use of [[tobacco]] products,<ref>{{cite journal | author=Joyce JW | title=Buerger's disease (thromboangiitis obliterans). | journal=Rheum Dis Clin North Am | year=1990 | pages=463-70 | volume=16 | issue=2 | id=PMID 2189162 }}</ref> primarily from [[Tobacco smoking|smoking]], but also from smokeless tobacco.  It is more often seen in men. There may be an autoimmune element as well.  Raynaud’s phenomenon, ulcers and pain are typically seen.  Immediate termination of smoking is essential.


==Features==
==Features==

Revision as of 21:36, 29 August 2012

For patient information click here

Buerger's disease
Buerger's Disease of the Hand
ICD-10 I73.1
ICD-9 443.1
OMIM 211480
DiseasesDB 1762
MeSH C14.907.137.870

Buerger's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Buerger's Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Buergers disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Buergers disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Buergers disease

CDC on Buergers disease

Buergers disease in the news

Blogs on Buergers disease

Directions to Hospitals Treating Buerger's disease

Risk calculators and risk factors for Buergers disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Thromboangiitis obliterans

Not to be confused with Berger's disease (IgA nephropathy)

Overview

Features

There is a recurrent acute and chronic inflammation and thrombosis of arteries and veins of the hands and feet. The main symptom is pain in the affected areas. Ulcerations and gangrene in the extremities are common complications, often resulting in the need for amputation of the involved extremity.

Diagnosis

A concrete diagnosis of thromboangiitis obliterans is often difficult as it relies heavily on exclusion of the conditions. The commonly followed diagnostic criteria are below although the criteria tend to differ slightly from author to author. Olin (2000) proposes the following criteria:[1]

  1. Age younger than 45 years
  2. Current (or recent) history of tobacco use
  3. Presence of distal extremity ischemia (indicated by claudication, pain at rest, ischemic ulcers or gangrene) documented by noninvasive vascular testing such as ultrasound
  4. Exclusion of autoimmune diseases, hypercoagulable states, and diabetes mellitus by laboratory tests.
  5. Exclusion of a proximal source of emboli by echocardiography and arteriography
  6. Consistent arteriographic findings in the clinically involved and noninvolved limbs.

Diagnostic Findings

Pathophysiology

There are characteristic pathologic findings of acute inflammation and thrombosis (clotting) of arteries and veins of the hands and feet (the lower limbs being more common). The mechanisms underlying Buerger's disease are still largely unknown. It is suspected that immunological reactions play a role.

Treatment

Symptoms are treated as there is no treatment for the disease. Cessation of tobacco use may slow any further progression of the disease. Vascular surgery can sometimes be helpful in treating limbs with poor perfusion secondary to this disease. Use of vascular growth factor and stem cell injections have been showing promise in clinical studies.

Prognosis

Amputation is common and more severe in patients who continue to use tobacco. It often leads to vascular insufficiency. Buerger's is rarely immediately fatal, but rather a life shortening disease.

Prevention

The cause of the disease is unknown but heavily linked to tobacco use. There have also been links to persons with digestive disorders.

Epidemiology

Buerger's is more common among men than women. It is more common in Israel, Japan and India along the "old silk route" than in the United States and Europe. The disease is most common among South Asians, who often smoke cigarettes made of raw tobacco (bidis).

History

Buerger's disease was first reported by Felix Von Winiwater in 1879 in Germany. [2]

It was described in detail by Leo Buerger in 1908 in New York,[3] who called it presenile spontaneous gangrene after studying amputations in 11 patients.

Pathology

<youtube v=whJF412vi2g/>

References

  1. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343:864-9. PMID 10995867.
  2. von Winiwarter F: Ueber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangran des Fusses. Arch Klin Chir 1879; 23: 202-26.
  3. Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80.

External Links

Buerger's Disease]


de:Endangiitis obliterans he:מחלת בירגר nl:Ziekte van Buerger sv:Morbus Buerger


Template:WikiDoc Sources